Market Place
Sourcing Support
Innate Pharma Sets Annual Shareholder Meeting for May 21
13 Apr 2026 //
BUSINESSWIRE
Number of Shares and Voting Rights of Innate Pharma as of April 9
13 Apr 2026 //
BUSINESSWIRE
Innate to Present at AACR Oncology Industry Partnering Event
08 Apr 2026 //
BUSINESSWIRE
Innate Pharma Files 2025 Universal Registration Document & 20-F
02 Apr 2026 //
PHARMIWEB
Innate Pharma to Participate in Kempen Life Sciences Conference
02 Apr 2026 //
BUSINESSWIRE
Innate Pharma Unveils 2025 Financials And Business Update
26 Mar 2026 //
PHARMIWEB
Innate Pharma Reports Shares, Voting Rights as of Feb. 19, 2026
19 Feb 2026 //
PHARMIWEB
Innate Pharma Reports Shares and Voting Rights as of Dec. 31
07 Jan 2026 //
PHARMIWEB
Innate Pharma Reports Shares, Voting Rights as of Dec. 18
22 Dec 2025 //
BUSINESSWIRE
Innate Pharma Releases Its 2026 Financial Calendar
11 Dec 2025 //
PHARMIWEB
Innate Pharma Reports Shares, Voting Rights as of Nov. 27
28 Nov 2025 //
BUSINESSWIRE
Innate Pharma to Present at Jefferies Healthcare Conference
17 Nov 2025 //
BUSINESSWIRE
Innate Pharma Updates Q3 2025 Business And Financials
13 Nov 2025 //
BUSINESSWIRE
Innate Pharma To Host Conference Call On Q3 2025 Results
05 Nov 2025 //
BUSINESSWIRE
Innate Pharma Participation at 25th European Midcap Event
15 Sep 2025 //
BUSINESSWIRE
Innate Pharma`s H1 Financial Results and Business Update Webcast
10 Sep 2025 //
PHARMAWEB
Number of Shares and Voting Rights of Innate Pharma as of Sept 1
02 Sep 2025 //
BUSINESSWIRE
Number of Shares and Voting Rights of Innate Pharma
04 Aug 2025 //
BUSINESSWIRE
Innate Pharma reports shares and voting rights as of July 3, 2025
04 Jul 2025 //
BUSINESSWIRE
Innate Pharma to Join Jefferies, Goldman Sachs Conferences
27 May 2025 //
BUSINESSWIRE
Outcome of Innate Pharma`s 2025 Annual General Meeting
23 May 2025 //
BUSINESSWIRE
Innate Pharma Highlights ASCO 2025 Meeting Abstracts
19 May 2025 //
BUSINESSWIRE
Innate Pharma Highlights Anket Abstracts at EHA 2025 Congress
15 May 2025 //
BUSINESSWIRE
Innate Pharma Reports Q1 2025 Business Update and Results
13 May 2025 //
BUSINESSWIRE
Innate Pharma`s Shares and Voting Rights as of May 5, 2025
12 May 2025 //
BUSINESSWIRE
Innate Pharma schedules Q1 2025 business update call
06 May 2025 //
BUSINESSWIRE
Innate Pharma`s Shares and Voting Rights as of April 25, 2025
28 Apr 2025 //
BUSINESSWIRE
Innate Pharma Announces 15M Investment by Sanofi
24 Apr 2025 //
BUSINESSWIRE
Innate Pharma proposes governance change to board of directors
16 Apr 2025 //
BUSINESSWIRE
Innate Pharma Annual General Meeting on May 22, 2025
16 Apr 2025 //
BUSINESSWIRE
Innate Pharma Reports 2024 Financial Results and Business Update
27 Mar 2025 //
BUSINESSWIRE
Innate Pharma`s IPH4502 Abstract Chosen for AACR 2025 Meeting
26 Mar 2025 //
BUSINESSWIRE
Innate Pharma to Hold Conference Call for Full Year 2024 Results
20 Mar 2025 //
BUSINESSWIRE
Innate To Join 2025 Leerink Partners Global Healthcare Conference
27 Feb 2025 //
BUSINESSWIRE
Innate Pharma Reports Shares And Voting Rights As Of Dec 31, 2024
16 Jan 2025 //
BUSINESSWIRE
Innate Pharma Announce Transformative Strategy to Accelerate Growth
09 Jan 2025 //
BUSINESSWIRE
Innate Pharma to Participate in 43rd J.P. Morgan Conference
20 Dec 2024 //
BUSINESSWIRE
Innate Pharma Highlights ASH 2024 Abstracts
02 Dec 2024 //
BUSINESSWIRE
Innate Pharma Reports Q3 2024 Business Update & Financial Results
13 Nov 2024 //
BUSINESSWIRE
Innate Pharma To Participate In Upcoming Investor Conferences
29 Oct 2024 //
BUSINESSWIRE
Innate Pharma Participate in Upcoming Investor Conferences
29 Oct 2024 //
BUSINESSWIRE
Innate Pharma Appoints Jonathan Dickinson As New CEO
14 Oct 2024 //
BUSINESSWIRE
Innate Pharma Hosts KOL Symposium On Immunotherapy, Oct 3
30 Sep 2024 //
BUSINESSWIRE
Innate Pharma Announces FDA Clearance Of IND For Solid Tumors
23 Sep 2024 //
BUSINESSWIRE
Innate Pharma Announces Call and Webcast for H1 2024 Financial Results
05 Sep 2024 //
BUSINESSWIRE
Innate Pharma to Participate in H.C. Wainwright Annual Investment Conference
04 Sep 2024 //
BUSINESSWIRE
Innate Pharma Announces Its Participation in Upcoming Investor Conference
31 Jul 2024 //
BUSINESSWIRE
Number of Shares and Voting Rights of Innate Pharma as of July 10, 2024
24 Jul 2024 //
BUSINESSWIRE
Innate Pharma Updates Sanofi`s SAR443579 IPH6101 Cancer Trial
18 Jun 2024 //
PHARMABIZ
Innate Pharma Shares Results From Sanofi`s Blood Cancer Phase 1/2 Trial
17 Jun 2024 //
BUSINESSWIRE
Innate Pharma Announces Its Participation in Upcoming Investor Conferences
28 May 2024 //
BUSINESSWIRE
Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting
24 May 2024 //
BUSINESSWIRE
Outcome of Innate Pharma’s 2024 Annual General Meeting
23 May 2024 //
BUSINESSWIRE
Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress
15 May 2024 //
BUSINESSWIRE
Innate Pharma Reports First Quarter 2024 Business Update and Financial Results
13 May 2024 //
BUSINESSWIRE
Innate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update
07 May 2024 //
BUSINESSWIRE
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 23, 2024
15 Apr 2024 //
BUSINESSWIRE
Innate Pharma Presents IPH45 Pre-IND Efficacy at AACR 2024
10 Apr 2024 //
BUSINESSWIRE
Innate Files Its 2023 Universal Registration Document & 2023 Annual Report
05 Apr 2024 //
BUSINESSWIRE
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
20 Mar 2024 //
BUSINESSWIRE
